CHIKUNGUNYA VIRUS INFECTIONS

Clinical trials for CHIKUNGUNYA VIRUS INFECTIONS explained in plain language.

Never miss a new study

Get alerted when new CHIKUNGUNYA VIRUS INFECTIONS trials appear

Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Scientists test nanoparticle vaccine against painful mosquito virus

⭐️ VACCINE ⭐️ Not yet recruiting

This is a first-in-human study to check the safety and immune response of a new experimental vaccine against chikungunya virus. The trial will enroll 40 healthy adults aged 18-60 who will receive two injections six weeks apart. Researchers will closely monitor participants for si…

Matched conditions: CHIKUNGUNYA VIRUS INFECTIONS

Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 12, 2026 13:50 UTC

CHIKUNGUNYA VIRUS INFECTIONS

Get alerted when new CHIKUNGUNYA VIRUS INFECTIONS trials appear

Scientists test nanoparticle vaccine against painful mosquito virus